BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders and is a great disease burden. However, its underlying pathophysiology and aetiology remain poorly understood. Available evidence suggests that circulating microRNAs (miRNAs) are associated with MDD, but it is still unknown whether miRNAs can predict subsequent incident MDD.METHODS: In this nested case-control study, a total of 104 individuals, who were free of MDD at baseline, from the Women's Health in Lund Area (WHILA) cohort were included. Among them, 52 individuals developed MDD (cases) during the 5 years follow-up and 52 individuals did not develop MDD (controls). Plasma expression levels of miR-17-5p, miR-134-5p, miR-144-5p, let-7b-5p and let-...
Major depressive disorder (MDD) is a neuropsychiatric disorder, which remains challenging to diagnos...
Purpose of review Major depressive disorder (MDD) is among the most prevalent and disabling medical ...
International audienceTo date, it remains impossible to guarantee that short-term treatment given to...
BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders and is a...
There is a growing emphasis in the field of psychiatry on the need to identify candidate biomarkers ...
Major depressive disorder (MDD) is a recurrent debilitating illness that represents a major health b...
The intracellular microRNAs that negatively regulate Toll-like receptor 4 signaling pathways in peri...
Background and Objectives: Currently, there is a serious need to find practical biomarker(s) for Maj...
Background: Major depressive disorder (MDD) presents with both peripheral and central alterations, s...
Major depression is a debilitating disease. To date, the development of biomarkers of major depressi...
Major Depressive Disorder (MDD) represents a major global health concern, a body-mind malady of risi...
Objective Major depressive disorder (MDD) is a recurrent disorder with an increasing incidence. Alte...
Aims: Our study aims to explore how miRNAs can elucidate the molecular mechanisms of major depressiv...
Major depression (MD) and bipolar disorder (BD) are severe and potentially life-threating mood disor...
Major depression (MD) and bipolar disorder (BD) are severe and potentially life-threating mood disor...
Major depressive disorder (MDD) is a neuropsychiatric disorder, which remains challenging to diagnos...
Purpose of review Major depressive disorder (MDD) is among the most prevalent and disabling medical ...
International audienceTo date, it remains impossible to guarantee that short-term treatment given to...
BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders and is a...
There is a growing emphasis in the field of psychiatry on the need to identify candidate biomarkers ...
Major depressive disorder (MDD) is a recurrent debilitating illness that represents a major health b...
The intracellular microRNAs that negatively regulate Toll-like receptor 4 signaling pathways in peri...
Background and Objectives: Currently, there is a serious need to find practical biomarker(s) for Maj...
Background: Major depressive disorder (MDD) presents with both peripheral and central alterations, s...
Major depression is a debilitating disease. To date, the development of biomarkers of major depressi...
Major Depressive Disorder (MDD) represents a major global health concern, a body-mind malady of risi...
Objective Major depressive disorder (MDD) is a recurrent disorder with an increasing incidence. Alte...
Aims: Our study aims to explore how miRNAs can elucidate the molecular mechanisms of major depressiv...
Major depression (MD) and bipolar disorder (BD) are severe and potentially life-threating mood disor...
Major depression (MD) and bipolar disorder (BD) are severe and potentially life-threating mood disor...
Major depressive disorder (MDD) is a neuropsychiatric disorder, which remains challenging to diagnos...
Purpose of review Major depressive disorder (MDD) is among the most prevalent and disabling medical ...
International audienceTo date, it remains impossible to guarantee that short-term treatment given to...